Access count of this item: 182

Files in This Item:
File Description SizeFormat 
31_2113.pdf420.57 kBAdobe PDFView/Open
Full metadata record
DC FieldValueLanguage
dc.contributor.author風間, 泰蔵ja
dc.contributor.author片山, 喬ja
dc.contributor.author山崎, 典昌ja
dc.contributor.alternativeKazama, Taizoja
dc.contributor.alternativeKatayama, Takashija
dc.contributor.alternativeYamazaki, Norimasaja
dc.date.accessioned2010-06-02T02:06:36Z-
dc.date.available2010-06-02T02:06:36Z-
dc.date.issued1985-12ja
dc.identifier.issn0018-1994ja
dc.identifier.urihttp://hdl.handle.net/2433/118701-
dc.description.abstract悪性腫瘍患者未治療群20例の血清TPAは,健康者37例に比して有意に高値を示した.良性疾患患者未治療群との間には,有意差は認められなかったが,尿TPAは有意に高値を示した.前立腺癌および膀胱癌患者の多くで血清および尿TPAは治療により低下した.前立腺癌患者では血清TPAとPAP間に有意の相関関係が成立した.良性疾患では尿路感染症をもつ症例は,ない症例に比して血清および尿TPAが上昇したja
dc.description.abstractWe measured the serum and urinary TPA in 64 patients with urological cancer, 55 patients with benign urological disease and 37 healthy volunteers. The serum TPA levels in patients with pre-treated cancer were significantly higher than those of healthy volunteers, but showed no significant difference compared to those in patients with a benign urological disease. The urinary TPA levels in patients with pre-treated cancer were significantly higher than those with a benign urological disease, but in some patients with urinary tract infection, very high urinary TPA concentrations were observed. Therefore, the determination of serum and urinary TPA may be useful in detecting urological cancer, but they were not specific tests. On the other hand, as lower serum and urinary TPA levels were observed after treatment of bladder and prostatic cancer, their determinations were considered to be useful in following up patients with these cancers.ja
dc.format.mimetypeapplication/pdfja
dc.language.isojpnja
dc.publisher泌尿器科紀要刊行会ja
dc.subjectAdolescentja
dc.subjectAdultja
dc.subjectChildja
dc.subjectChild, Preschoolja
dc.subjectFemaleja
dc.subjectHumansja
dc.subjectKidney Neoplasms/immunologyja
dc.subjectMaleja
dc.subjectMiddle Agedja
dc.subjectPeptides/analysisja
dc.subjectProstatic Neoplasms/immunologyja
dc.subjectTissue Polypeptide Antigenja
dc.subjectUrinary Bladder Neoplasms/immunologyja
dc.subjectUrologic Neoplasms/immunologyja
dc.subject.ndc494.9ja
dc.title泌尿器科領域における血清および尿中Tissue polypeptide antigen (TPA)の検討ja
dc.title.alternativeSerum and urinary tissue polypeptide antigen (TPA) in patients with urological cancerja
dc.type.niitypeDepartmental Bulletin Paperja
dc.identifier.ncidAN00208315ja
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume31ja
dc.identifier.issue12ja
dc.identifier.spage2113ja
dc.identifier.epage2119ja
dc.textversionpublisherja
dc.sortkey02ja
dc.address富山医科薬科大学医学部泌尿器科学教室ja
dc.address.alternativeThe Department of Urology, Faculty of Nledicine, Toyama Medical and Pharmaceutical Universityja
dc.identifier.pmid3832915ja
Appears in Collections:Vol.31 No.12

Show simple item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.